1 December 2024 false No description of principal activity Taxfiler 2024.6 15270640 business:PrivateLimitedCompanyLtd 2024-12-01 2025-12-31 15270640 2024-11-30 15270640 2024-12-01 2025-12-31 15270640 business:AuditExempt-NoAccountantsReport 2024-12-01 2025-12-31 15270640 business:AbridgedAccounts 2024-12-01 2025-12-31 15270640 2025-12-31 15270640 business:Director1 2024-12-01 2025-12-31 15270640 business:RegisteredOffice 2024-12-01 2025-12-31 15270640 2024-11-30 15270640 core:WithinOneYear 2025-12-31 15270640 core:WithinOneYear 2024-11-30 15270640 core:ShareCapital core:PreviouslyStatedAmount 2025-12-31 15270640 core:ShareCapital core:PreviouslyStatedAmount 2024-11-30 15270640 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-12-31 15270640 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-11-30 15270640 core:PreviouslyStatedAmount 2025-12-31 15270640 core:PreviouslyStatedAmount 2024-11-30 15270640 business:SmallEntities 2024-12-01 2025-12-31 15270640 countries:EnglandWales 2024-12-01 2025-12-31 15270640 2023-11-08 2024-11-30 iso4217:GBP xbrli:pure
Company Registration No. 15270640 (England and Wales)
Big Pharma Limited Unaudited accounts for the period from 1 December 2024 to 31 December 2025
Big Pharma Limited Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Big Pharma Limited Company Information for the period from 1 December 2024 to 31 December 2025
Director
HUSSAIN, Hassan
Company Number
15270640 (England and Wales)
Registered Office
5 Spinners Close Halifax West Yorkshire HX1 4RT England
- 3 -
Big Pharma Limited Statement of financial position as at 31 December 2025
2025
2024
Notes
£
£
Current assets
Debtors
-
3,528
Cash at bank and in hand
-
10,516
-
14,044
Creditors: amounts falling due within one year
100
(13,728)
Net current assets
100
316
Net assets
100
316
Capital and reserves
Called up share capital
100
100
Profit and loss account
-
216
Shareholders' funds
100
316
For the period ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The members have agreed to the preparation of abridged accounts for the period in accordance with Section 444(2A).
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 12 March 2026 and were signed on its behalf by
HUSSAIN, Hassan Director Company Registration No. 15270640
- 4 -
Big Pharma Limited Notes to the Accounts for the period from 1 December 2024 to 31 December 2025
1
Statutory information
Big Pharma Limited is a private company, limited by shares, registered in England and Wales, registration number 15270640. The registered office is 5 Spinners Close, Halifax, West Yorkshire, HX1 4RT, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous period, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Average number of employees
During the period the average number of employees was 1 (2024: 1).
- 5 -